Physician profile
Peter Chudolij
NPI 1639899438
$3,695.58
in general payments reported to CMS, 2019-2025
14 companies · $1,486 in 2025
The $1,486 reported for 2025 was more than what 95% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $112 · 2023: $364 · 2024: $1,733 · 2025: $1,486.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,340 · Travel and Lodging: $244.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,339.63 |
| Travel and Lodging | $243.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $896.70 | 2024-2025 | Myday Contact Lens, Synergeyes Contact Lens, Misight Contact Lens |
| Alcon Vision LLC | $800.63 | 2023-2025 | Dailies Total1, Tryptyr, Clareon |
| Tarsus Pharmaceuticals, INC. | $406.97 | 2024-2025 | Xdemvy |
| Bausch & Lomb Americas INC. | $400.73 | 2022-2025 | Miebo, Xiidra, Blink Nutritears |
| Harrow Eye, LLC | $277.21 | 2024-2025 | Vevye |
| Dompe US, INC. | $202.75 | 2024-2025 | Oxervate |
| Sun Pharmaceutical Industries INC. | $187.95 | 2023-2025 | Cequa |
| Oyster Point Pharma, INC. | $140.99 | 2023-2025 | Tyrvaya |
| Rxsight INC | $121.67 | 2025 | Rxsight Injector Cartridge, Rxsight Light Delivery Device (Ldd), Light Adjustable Lens (Lal) |
| Johnson & Johnson Surgical Vision, INC. | $106.27 | 2023 | Tecnis Iol |
| Visioneering Technologies, INC. | $102.57 | 2025 | |
| Biotissue Holdings INC. | $20.17 | 2024 | |
| Apellis Pharmaceuticals, INC. | $16.00 | 2023 | Syfovre |
| Abbvie INC. | $14.97 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Chudolij listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.